Further pre-clinical work that utilises the myocardial ischaemia-reperfusion model and includes relevant comorbidities and aged mice would further our understanding of the applicability of MPO inhibition to the acute clinical treatment of post-MI cardiac dysfunction. Here, MPO is linked to myocardial infarction.